Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Basal Cell × cemiplimab × Clear all

Status

Sponsor Class

Study Type

Interventional 3 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Sexual Dysfunction, Physiological 1 PROMs 1 Neoplasms 1 Locally Advanced Melanoma 1 Eunuchism 1 Erectile Dysfunction 1 Cutaneous Squamous Cell Carcinoma (CSCC) 1 Carcinoma, Basal Cell 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Tomography, Optical Coherence 2 Mohs Surgery 2 Imiquimod 2 HhAntag691 2 cemiplimab 1 Watchful Waiting 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Spectrum Analysis, Raman 1 Predictive Learning Models 1 Patient Reported Outcome Measures 1 Microscopy, Confocal 1 Microarray Analysis 1 Intravital Microscopy 1 Immunotherapy 1 Dermoscopy 1 Blood Specimen Collection 1 Biopsy 1 Aftercare 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03836105 2025-10-15

CASE

Regeneron Pharmaceuticals

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡